Pharmobedient Drug Patent Portfolio
Pharmobedient owns 5 orange book drugs protected by 10 US patents with Accuneb having the least patent protection, holding only 1 patent. And Olux E with maximum patent protection, holding 4 patents. Given below is the list of Pharmobedient's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8460641 | Microemulsion process and composition | 05 Nov, 2028 | Active |
| US8962000 | Microemulsion and sub-micron emulsion process and compositions | 31 Aug, 2025 | Active |
| US6702997 | Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma | 28 Dec, 2021 | Expired |
| US6632842 | Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease | 28 Dec, 2021 | Expired |
| US6730288 | Mousse composition | 08 Sep, 2019 | Expired |
| US7029659 | Mousse composition | 08 Sep, 2019 | Expired |
| US5980867 | Flunisolide aerosol formulations | 06 Jul, 2018 | Expired |
| US7078058 | Corticosteroid-containing pharmaceutical composition | 24 May, 2017 | Expired |
| US6126920 | Method of treating a skin disease with a corticosteroid-containing pharmaceutical composition | 01 Mar, 2016 | Expired |
| US5776433 | Flunisolide aerosol formulations | 07 Jul, 2015 | Expired |
Latest Legal Activities on Pharmobedient's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Pharmobedient.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 28 Sep, 2020 | US8460641 |
| File Marked Found | 03 Jul, 2019 | US6702997 |
| File Marked Found | 17 Oct, 2018 | US6632842 |
| File Marked Found | 02 Oct, 2018 | US6702997 |
|
Expire Patent
Critical
| 13 Aug, 2018 | US7078058 |
|
Maintenance Fee Reminder Mailed
Critical
| 26 Feb, 2018 | US7078058 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 14 Sep, 2017 | US7029659 (Litigated) |
| Post Issue Communication - Certificate of Correction | 04 Dec, 2014 | US8460641 |
|
Email Notification
Critical
| 03 Oct, 2014 | US8460641 |
|
Mail-Petition Decision - Dismissed
Critical
| 30 Sep, 2014 | US8460641 |
|
Petition Decision - Dismissed
Critical
| 29 Sep, 2014 | US8460641 |
| Adjustment of PTA Calculation by PTO | 27 Sep, 2014 | US8460641 |
|
Correspondence Address Change
Critical
| 13 Jun, 2014 | US6702997 |
| Post Issue Communication - Certificate of Correction | 04 Oct, 2013 | US8460641 |
| Petition Entered | 09 Aug, 2013 | US8460641 |
Pharmobedient Drug Patents' Oppositions Filed in EPO
Pharmobedient drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on May 14, 2014, by Generics [Uk] Limited. This opposition was filed on patent number EP05775966A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
 | |||
| EP05775966A | May, 2014 | Henkel AG & Co. KGaA | Patent maintained as amended |
| EP05775966A | May, 2014 | Generics [UK] Limited | Patent maintained as amended |
Pharmobedient's Family Patents
Pharmobedient Drug List
Given below is the complete list of Pharmobedient's drugs and the patents protecting them.
1. Accuneb
Accuneb is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6702997 | Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma |
28 Dec, 2021
(3 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Accuneb's drug page
2. Aerospan Hfa
Aerospan Hfa is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5980867 | Flunisolide aerosol formulations |
06 Jul, 2018
(7 years ago)
| Expired |
| US5776433 | Flunisolide aerosol formulations |
07 Jul, 2015
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Aerospan Hfa's drug page
3. Duoneb
Duoneb is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6632842 | Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
28 Dec, 2021
(3 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Duoneb's drug page
4. Luxiq
Luxiq is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7078058 | Corticosteroid-containing pharmaceutical composition |
24 May, 2017
(8 years ago)
| Expired |
| US6126920 | Method of treating a skin disease with a corticosteroid-containing pharmaceutical composition |
01 Mar, 2016
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Luxiq's drug page
5. Olux E
Olux E is protected by 4 patents, out of which 2 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8460641 | Microemulsion process and composition |
05 Nov, 2028
(3 years from now)
| Active |
| US8962000 | Microemulsion and sub-micron emulsion process and compositions |
31 Aug, 2025
(a month from now)
| Active |
| US6730288 | Mousse composition |
08 Sep, 2019
(5 years ago)
| Expired |
| US7029659 | Mousse composition |
08 Sep, 2019
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Olux E's drug page